The American Society of Clinical Oncology–Faculty of yank Pathologists (ASCO–CAP) recommendations have continued to evolve to Enhance the precision and clinical utility of HER2 testing by offering particular algorithms15,sixteen. In parallel with existing strategies, novel ways to quantify HER2 ranges or standardize methods are now being investigated, which include quantitative https://www.directivepublications.org/journal-of-clinical-breast-cancer/